Table 2.
Characteristics of study participants after splitting them in osteoporotic and no osteoporotic
| Osteoporosis | Non osteopotic patients | P valuea | |
| Number | 40 | 32 | |
| Number of individuals with plaque | |||
| Femoral Plaque | 19 (47.5) | 16 (50.0) | 0.393 |
| Carotid Plaque | 2 (5.0) | 1 (3.1) | 1.000 |
| Plaques echogenicity | |||
| Type I echolucent | 5 (12.5) | 6 (22.2) | 0.241 |
| Type II predominantly echolucent | 8 (20.0) | 2 (06.2) | |
| Type III predominantly echogenic | 3 (7.5) | 7 (21.8) | |
| Type IV echogenic | 3 (7.5) | 2 (06.2) | |
| Mean (SD) | |||
| Age (years) | 59.1 ± 6.2 | 58.7 ± 6.5 | 0.797 |
| Menopause age (yeras) | 48.6 ± 5.5 | 48.0 ± 6.2 | 0.724 |
| Number of pregnencies | 6.0 ± 2.6 | 4.0 ± 2.0 | 0.193 |
| Body mass index (kg/m2) | 28.3 ± 4.0 | 26.3 ± 5.1 | 0.193 |
| Physical activity score | 2160 ± 1546 | 3690 ± 2134 | 0.200 |
| Serum level | |||
| Triglyceride (g/l) | 1.25 ± 0.41 | 0.97 ± 0.32 | 0.094 |
| Total Cholesterol (g/l) | 2.05 ± 0.30 | 2.06 ± 0.31 | 0.934 |
| high-density lipoprotein (g/l) | 0.55 ± 0.12 | 0.59 ± 0.19 | 0.572 |
| low-density lipoprotein (g/l) | 1.25 ± 0.24 | 1.27 ± 0.24 | 0.645 |
| Calcium (mg/l) | 97.33 ± 5.87 | 98.14 ± 5.15 | 0.533 |
| Phosphorus (mg/l) | 35.80 ± 4.60 | 37.20 ± 3.20 | 0.348 |
| 25 OH D3 (μg/l) | 15.36 ± 7.46 | 16.01 ± 5.77 | 0.699 |